Arovella speaking at ANZ Biologics Festival
Arovella’s Chief Operating Officer, Dr Nicole van der Weerden, is speaking today at the ANZ Biologics Festival. Dr van der Weerden is speaking about the development of CAR-iNKT cells for the treatment and haematological malignancies and solid tumours.
